Correction: J Exp Clin Cancer Res (2024) 43:74
Following publication of the original article [1], errors were spotted particularly in Funding section. The correct funding statement is stated below:
Incorrect Funding
This work was supported by the National Natural Science Foundation of China (Grant Nos. 81,627,901, 82,203,014, 81,972,863, (Grant Nos. 81,627,901, 82,203,014, 81,972,863, 82,030,082, and 22,307,068), the Radiation Oncology Innovate Unit, Chinese Academy of Medical Sciences (Grant No. 2019RU071), the Natural Science Foundation of Shandong Province (Grant Nos. ZR2022QH017 and ZR2022QB015), the Academic Promotion Program of Shandong First Medical University (Grant No. 2019ZL002), the China Postdoctoral Science Foundation (Grant No. 2023M742149), and the Taishan Scholars Program (Grant No. tsqn202306386).
Correct Funding
This work was supported by the National Natural Science Foundation of China (Grant Nos. 81,627,901), the National Natural Science Foundation of China (Grant Nos. 82,203,014, 81,972,863, 82,030,082, and 22,307,068), the Radiation Oncology Innovate Unit, Chinese Academy of Medical Sciences (Grant No. 2019RU071), the Natural Science Foundation of Shandong Province (Grant Nos. ZR2022QH017 and ZR2022QB015), the Academic Promotion Program of Shandong First Medical University (Grant No. 2019ZL002), the China Postdoctoral Science Foundation (Grant No. 2023M742149), and the Taishan Scholars Program (Grant No. tsqn202306386).
The corrections do not affect the overall result or conclusion of the article. The original article has been corrected.
References
Wang B, Pei J, Xu S et al (2024) A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle. J Exp Clin Cancer Res 43:74 https://doi.org/10.1186/s13046-024-02994-0
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13046-024-02994-0.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Wang, B., Pei, J., Xu, S. et al. Correction: A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle. J Exp Clin Cancer Res 43, 93 (2024). https://doi.org/10.1186/s13046-024-03018-7
Published:
DOI: https://doi.org/10.1186/s13046-024-03018-7